首页 > 最新文献

Laeknabladid最新文献

英文 中文
[Eosinophilic esophagitis]. [嗜酸性粒细胞食管炎]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.17992/lbl.2024.09.806
Johann Pall Hreinsson
{"title":"[Eosinophilic esophagitis].","authors":"Johann Pall Hreinsson","doi":"10.17992/lbl.2024.09.806","DOIUrl":"https://doi.org/10.17992/lbl.2024.09.806","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 10","pages":"455"},"PeriodicalIF":0.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Licorice consumption can be life-threatening]. [食用甘草会危及生命]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.17992/lbl.2024.09.809
Olafur Orri Sturluson, Birgir Johannsson, Helga Agusta Sigurjonsdottir

A 71-year-old man came to the emergency department (ED) at Landspitali University Hospital after collapsing at his home. He had a severely decreased serum potassium concentration of 2.1 mmol/L (ref. 3,5-4,8 mmol/L), along with an influenza A infection and thigh muscle weakness. Further investigations revealed atrial fibrillation, new-onset hypertension and increased urinary excretion of potassium. Serum values of aldosterone and renin were under the limit of detection. The patient had consumed a significant amount of liquorice with marzipan, over 250g per day, in the days preceding his visit to the ED. He was subsequently diagnosed with liquorice-induced hypertension and syndome of apparent mineralocordicoid excess (pseudohyperaldosteronism). This case emphasizes the need for clinicians to be aware of the dangers of liquorice consumption.

一名 71 岁的男子在家中晕倒后,来到兰茨皮塔利大学医院急诊科(ED)就诊。他的血清钾浓度严重下降至 2.1 mmol/L(参考值为 3.5-4.8 mmol/L),并伴有甲型流感感染和大腿肌肉无力。进一步检查发现他患有心房颤动、新发高血压和尿钾排泄增加。血清中的醛固酮和肾素值低于检测限。患者在来急诊室就诊前几天食用了大量甘草和杏仁蛋白,每天超过 250 克。随后,他被诊断为甘草诱发的高血压和明显的促矿物质生成素过多综合征(假性高醛固酮症)。本病例强调临床医生需要注意食用甘草的危害。
{"title":"[Licorice consumption can be life-threatening].","authors":"Olafur Orri Sturluson, Birgir Johannsson, Helga Agusta Sigurjonsdottir","doi":"10.17992/lbl.2024.09.809","DOIUrl":"https://doi.org/10.17992/lbl.2024.09.809","url":null,"abstract":"<p><p>A 71-year-old man came to the emergency department (ED) at Landspitali University Hospital after collapsing at his home. He had a severely decreased serum potassium concentration of 2.1 mmol/L (ref. 3,5-4,8 mmol/L), along with an influenza A infection and thigh muscle weakness. Further investigations revealed atrial fibrillation, new-onset hypertension and increased urinary excretion of potassium. Serum values of aldosterone and renin were under the limit of detection. The patient had consumed a significant amount of liquorice with marzipan, over 250g per day, in the days preceding his visit to the ED. He was subsequently diagnosed with liquorice-induced hypertension and syndome of apparent mineralocordicoid excess (pseudohyperaldosteronism). This case emphasizes the need for clinicians to be aware of the dangers of liquorice consumption.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 10","pages":"464-468"},"PeriodicalIF":0.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[On autopilot: is it unevitable that our fast paced living drives us to ultra-processed foods?] [自动驾驶:我们的快节奏生活是否不可避免地促使我们食用超加工食品?]
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: doi 10.17992/lbl.2024.09.803
Anna Sigridur Olafsdottir
{"title":"[On autopilot: is it unevitable that our fast paced living drives us to ultra-processed foods?]","authors":"Anna Sigridur Olafsdottir","doi":"doi 10.17992/lbl.2024.09.803","DOIUrl":"https://doi.org/doi 10.17992/lbl.2024.09.803","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 9","pages":"401"},"PeriodicalIF":0.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[#ADHD]. [#ADHD]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.17992/lbl.2024.09.802
Elvar Danielsson
{"title":"[#ADHD].","authors":"Elvar Danielsson","doi":"10.17992/lbl.2024.09.802","DOIUrl":"10.17992/lbl.2024.09.802","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 9","pages":"399"},"PeriodicalIF":0.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The efficacy of magnetic transcranial stimulation in treating treatment-resistant or prolonged depression in a clinical sample]. [经颅磁刺激治疗临床样本中的抗药性抑郁症或长期抑郁症的疗效]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.17992/lbl.2024.09.805
Elin Maria Arnadottir, Nicolas Petur Blin, Jon Gauti Jonsson, Dagur Bjarnason, Engilbert Sigurdsson

Introduction: Depression is a common, serious and often chronic disorder and one of the leading causes of disability worldwide. The annual prevalence of depression is 5-10%, twice as high among women as men and the lifetime prevalence is at least 20%. Up to a third of depressed individuals meet criteria for treatment-resistant depression, where two antidepressants have been tried for at least 6 weeks each at therapeutic doses. As of January 2022 transcranial magnetic stimulation for adults with treatment-resistant depression that has not responded to other forms of treatment has been available by a service that is part of Primary Health Care of the Capital Area in Iceland.

Methods: This is a retrospective cohort study where participants completed a course of magnetic transcranial treatment for depression in the years 2022 and 2023. Two validated self-rating measures were used to assess depression. Information on previous treatment approaches for depression was collected from electronic health records.

Results: 104 individuals completed the treatment in these first two years, 60,6% women. Most had unipolar depression (86,5%), but a small subgroup had bipolar depression (13,5%). The proportion of responders varied according to the measures used, 36,1% and 45,7%, respectively, and the same was true for remission where the proportions were 12,4% and 31,5%, respectively, higher for the longer inventory. The drop-out rate was only 12,5% and no serious adverse events were reported during the treatment.

Conclusion: The results support that magnetic transcranial stimulation, as provided by this service is effective in treating treatment-resistant or longstanding depression in a real life clinical setting and the low drop-out rate supports that the treatment is generally very well tolerated.

简介抑郁症是一种常见的、严重的、往往是慢性的疾病,也是导致全球残疾的主要原因之一。抑郁症的年患病率为 5-10%,女性患病率是男性的两倍,终生患病率至少为 20%。多达三分之一的抑郁症患者符合耐药性抑郁症的标准,即已尝试过两种抗抑郁药物,每种药物的治疗剂量至少为 6 周。从 2022 年 1 月起,冰岛首都地区初级医疗保健的一项服务开始提供经颅磁刺激治疗,用于治疗对其他治疗方式无效的成人耐药性抑郁症患者:这是一项回顾性队列研究,参与者在 2022 年和 2023 年完成了经颅磁刺激治疗抑郁症的疗程。研究采用了两种经过验证的自我评分方法来评估抑郁症。研究人员从电子健康记录中收集了有关以往抑郁症治疗方法的信息:104 人在头两年完成了治疗,其中 60.6% 为女性。大多数人患有单相抑郁症(86.5%),但也有一小部分人患有双相抑郁症(13.5%)。有反应者的比例因采用的测量方法而异,分别为 36.1% 和 45.7%,缓解者的比例也是如此,分别为 12.4% 和 31.5%,时间较长的清单中的比例更高。辍学率仅为 12.5%,治疗期间未出现严重不良反应:研究结果表明,在真实的临床环境中,这项服务所提供的经颅磁刺激疗法可有效治疗耐药性抑郁症或长期抑郁症。
{"title":"[The efficacy of magnetic transcranial stimulation in treating treatment-resistant or prolonged depression in a clinical sample].","authors":"Elin Maria Arnadottir, Nicolas Petur Blin, Jon Gauti Jonsson, Dagur Bjarnason, Engilbert Sigurdsson","doi":"10.17992/lbl.2024.09.805","DOIUrl":"https://doi.org/10.17992/lbl.2024.09.805","url":null,"abstract":"<p><strong>Introduction: </strong>Depression is a common, serious and often chronic disorder and one of the leading causes of disability worldwide. The annual prevalence of depression is 5-10%, twice as high among women as men and the lifetime prevalence is at least 20%. Up to a third of depressed individuals meet criteria for treatment-resistant depression, where two antidepressants have been tried for at least 6 weeks each at therapeutic doses. As of January 2022 transcranial magnetic stimulation for adults with treatment-resistant depression that has not responded to other forms of treatment has been available by a service that is part of Primary Health Care of the Capital Area in Iceland.</p><p><strong>Methods: </strong>This is a retrospective cohort study where participants completed a course of magnetic transcranial treatment for depression in the years 2022 and 2023. Two validated self-rating measures were used to assess depression. Information on previous treatment approaches for depression was collected from electronic health records.</p><p><strong>Results: </strong>104 individuals completed the treatment in these first two years, 60,6% women. Most had unipolar depression (86,5%), but a small subgroup had bipolar depression (13,5%). The proportion of responders varied according to the measures used, 36,1% and 45,7%, respectively, and the same was true for remission where the proportions were 12,4% and 31,5%, respectively, higher for the longer inventory. The drop-out rate was only 12,5% and no serious adverse events were reported during the treatment.</p><p><strong>Conclusion: </strong>The results support that magnetic transcranial stimulation, as provided by this service is effective in treating treatment-resistant or longstanding depression in a real life clinical setting and the low drop-out rate supports that the treatment is generally very well tolerated.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 9","pages":"411-417"},"PeriodicalIF":0.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[High prevalence of treatment with ADHD medicines indicates overdiagnosis of ADHD in Iceland]. [使用多动症药物治疗的高发病率表明冰岛对多动症的过度诊断]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.17992/lbl.2024.09.804
Oddur Ingimarsson, Ragna Kristin Gudbrandsdottir, Bertrand Andre Marc Lauth, Engilbert Sigurdsson

Introduction: ADHD is a neurodevelopmental disorder characterized by hyperactivity, inattention and impulsivity. For many the core symptoms become less troubling in adulthood. Treatment with stimulants is considered the most efficacious treatment for ADHD. Large high-quality studies have estimated the prevalence of AHDH to be 3,4-7,2% for children and adolescents and 2,5-6,8% for young adults. The aim of this study was to estimate the proportion of Icelanders who have received an ADHD diagnosis based on ADHD-medication prescriptions since an ADHD diagnosis is a prerequisite for such prescriptions in Iceland.

Methods: This population-based retrospective cohort study included all Icelanders 7-70 years old who received a prescription for an ADHD drug from 1.1.2004-31.12.2023. Every citizen receiving a prescription is included in the Icelandic Prescription Medicines Registry (IPMR).

Results: In 2023 14,7% of youth, 7-17 years of age, received a prescription for an ADHD medication, 17,7% of boys and 11,6% of girls. Among 12-17 years old youth the proportion was higher still, 17,6%, 20,1% for boys and 14,6% for girls. For 18-44 years old adults the proportion was 10,2%, 9,4% for males and 11,0% for females. From 2010-2023 the increase in prescriptions for 7-17 years old boys has been 93% but 224% for girls. For 18-44 years old males the increase has been 414% for males and 543% for females during this period. The incidence of new ADHD prescriptions for 7-17 years old boys from 2021-2023 was 10,9 and 13,5 for girls per 1000, respectively. For 18-44 years old the incidence in the years 2021-2023 was 18,7 for males and 19,2 for females per 1000, respectively.

Conclusion: The prevalence of Icelanders who have received an ADHD diagnosis is double to treble that observed in the best available studies in other populations. We therefore call for an urgent review of how ADHD diagnoses are made in Iceland because it is obvious that the current system leads to overdiagnosis and inappropriate treatment.

简介多动症是一种以多动、注意力不集中和冲动为特征的神经发育障碍。对许多人来说,成年后核心症状的困扰会减轻。使用兴奋剂治疗被认为是治疗多动症最有效的方法。据大量高质量的研究估计,儿童和青少年多动症的发病率为 3.4%-7.2%,年轻成年人为 2.5%-6.8%。本研究的目的是根据ADHD药物处方,估算出接受过ADHD诊断的冰岛人比例,因为在冰岛,ADHD诊断是此类处方的先决条件:这项以人口为基础的回顾性队列研究包括所有在2004年1月1日至2023年12月31日期间收到ADHD药物处方的7-70岁冰岛人。每位接受处方的公民都被纳入冰岛处方药登记处(IPMR):结果:2023 年,14.7% 的 7-17 岁青少年获得了多动症药物处方,其中男孩占 17.7%,女孩占 11.6%。在 12-17 岁的青少年中,这一比例更高,为 17.6%,其中男孩为 20.1%,女孩为 14.6%。在 18-44 岁的成年人中,这一比例为 10.2%,其中男性为 9.4%,女性为 11.0%。2010-2023 年间,7-17 岁男孩的处方量增长了 93%,而女孩则增长了 224%。在此期间,18-44 岁男性的处方量增长了 414%,女性增长了 543%。2021-2023 年期间,7-17 岁男孩和女孩的多动症新处方发生率分别为 10.9%.和 13.5%.。2021-2023年期间,18-44岁的男性和女性多动症的发病率分别为每1000人中18.7人和19.2人:结论:冰岛人被诊断为多动症的发病率是其他人群中现有最佳研究结果的两倍到三倍。因此,我们呼吁对冰岛诊断多动症的方式进行紧急审查,因为现行制度显然会导致过度诊断和不当治疗。
{"title":"[High prevalence of treatment with ADHD medicines indicates overdiagnosis of ADHD in Iceland].","authors":"Oddur Ingimarsson, Ragna Kristin Gudbrandsdottir, Bertrand Andre Marc Lauth, Engilbert Sigurdsson","doi":"10.17992/lbl.2024.09.804","DOIUrl":"https://doi.org/10.17992/lbl.2024.09.804","url":null,"abstract":"<p><strong>Introduction: </strong>ADHD is a neurodevelopmental disorder characterized by hyperactivity, inattention and impulsivity. For many the core symptoms become less troubling in adulthood. Treatment with stimulants is considered the most efficacious treatment for ADHD. Large high-quality studies have estimated the prevalence of AHDH to be 3,4-7,2% for children and adolescents and 2,5-6,8% for young adults. The aim of this study was to estimate the proportion of Icelanders who have received an ADHD diagnosis based on ADHD-medication prescriptions since an ADHD diagnosis is a prerequisite for such prescriptions in Iceland.</p><p><strong>Methods: </strong>This population-based retrospective cohort study included all Icelanders 7-70 years old who received a prescription for an ADHD drug from 1.1.2004-31.12.2023. Every citizen receiving a prescription is included in the Icelandic Prescription Medicines Registry (IPMR).</p><p><strong>Results: </strong>In 2023 14,7% of youth, 7-17 years of age, received a prescription for an ADHD medication, 17,7% of boys and 11,6% of girls. Among 12-17 years old youth the proportion was higher still, 17,6%, 20,1% for boys and 14,6% for girls. For 18-44 years old adults the proportion was 10,2%, 9,4% for males and 11,0% for females. From 2010-2023 the increase in prescriptions for 7-17 years old boys has been 93% but 224% for girls. For 18-44 years old males the increase has been 414% for males and 543% for females during this period. The incidence of new ADHD prescriptions for 7-17 years old boys from 2021-2023 was 10,9 and 13,5 for girls per 1000, respectively. For 18-44 years old the incidence in the years 2021-2023 was 18,7 for males and 19,2 for females per 1000, respectively.</p><p><strong>Conclusion: </strong>The prevalence of Icelanders who have received an ADHD diagnosis is double to treble that observed in the best available studies in other populations. We therefore call for an urgent review of how ADHD diagnoses are made in Iceland because it is obvious that the current system leads to overdiagnosis and inappropriate treatment.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 9","pages":"402-410"},"PeriodicalIF":0.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[What time is it?] [几点了? ]
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 DOI: 10.17992/lbl.2024.0708.799
Eirikur Jonsson
{"title":"[What time is it?]","authors":"Eirikur Jonsson","doi":"10.17992/lbl.2024.0708.799","DOIUrl":"10.17992/lbl.2024.0708.799","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 7","pages":"353"},"PeriodicalIF":0.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet]. [肠易激综合征患者采用低 FODMAP 饮食后的胃肠道症状和饮食摄入量]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-06-01 DOI: 10.17992/lbl.2024.06.796
Ingunn Erla Ingvarsdóttir, Svava Engilbertsdottir, T. Halldorsson, E. S. Bjornsson, I. Gunnarsdottir
INTRODUCTIONHigh FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.MATERIALS AND METHODSA total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).RESULTSThe number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).CONCLUSIONBoth groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.
简介高 FODMAP(可发酵低聚糖、双糖、单糖和多元醇)食物与肠易激综合征患者症状的恶化有关。材料和方法将符合罗马IV标准的54名肠易激综合征患者随机分为两组,即指导组(个体营养治疗,28人)和自我管理组(在网上了解低FODMAP饮食,26人)。两组均遵循低 FODMAP 饮食 4 周。采用四天食物记录来评估饮食摄入量。结果未完成研究的受试者人数为13人,其中营养治疗组5人,自我管理组8人,可供分析的受试者人数分别为23人和18人。从基线到终点,两组受试者的症状均有所减轻,营养治疗组平均减轻了183±101分(P< 0.001),自我管理组平均减轻了132±110分(P< 0.001),组间无差异。基线时,两组中约有 80% 的膳食中含有高 FODMAP 食物。结论两组患者的症状均有所缓解,但与仅接受如何在线了解低 FODMAP 饮食指导的组别相比,接受个体营养治疗的组别对低 FODMAP 饮食的依从性更好。
{"title":"[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].","authors":"Ingunn Erla Ingvarsdóttir, Svava Engilbertsdottir, T. Halldorsson, E. S. Bjornsson, I. Gunnarsdottir","doi":"10.17992/lbl.2024.06.796","DOIUrl":"https://doi.org/10.17992/lbl.2024.06.796","url":null,"abstract":"INTRODUCTION\u0000High FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.\u0000\u0000\u0000MATERIALS AND METHODS\u0000A total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).\u0000\u0000\u0000RESULTS\u0000The number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).\u0000\u0000\u0000CONCLUSION\u0000Both groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"41 48","pages":"298-306"},"PeriodicalIF":0.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141232741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet]. [肠易激综合征患者采用低 FODMAP 饮食后的胃肠道症状和饮食摄入量]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-06-01 DOI: 10.17992/lbl.2024.05.796
Ingunn Erla Ingvarsdottir, Svava Engilbertsdottir, Thorhallur Ingi Halldorsson, Einar Stefan Bjornsson, Ingibjorg Gunnarsdottir

Introduction: High FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.

Materials and methods: A total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).

Results: The number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).

Conclusion: Both groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.

导言:高 FODMAP(可发酵低聚糖、双糖、单糖和多元醇)食物与肠易激综合征患者症状的恶化有关。本研究旨在比较肠易激综合征患者在接受或不接受个体营养治疗的情况下摄入低 FODMAP 饮食后的胃肠道症状和饮食摄入量:54名符合罗马IV标准的肠易激综合征患者被随机分为两组,指导组(个体营养治疗,28人)和自我管理组(在线了解低FODMAP饮食,26人)。两组均遵循低 FODMAP 饮食 4 周。采用四天食物记录来评估饮食摄入量。通过肠易激综合征严重程度评分系统(ISB-SSS)对症状进行评估:未完成研究的受试者人数为 13 人,其中营养治疗组 5 人,自我管理组 8 人,可供分析的受试者人数分别为 23 人和 18 人。从基线到终点,两组受试者的症状均有所减轻,营养治疗组平均减轻了183±101分(P< 0.001),自我管理组平均减轻了132±110分(P< 0.001),组间无差异。基线时,两组中约有 80% 的膳食含有高 FODMAP 食物。营养治疗组和自我管理组在第3周的相应比例分别为9%和36%(P< 0.001):结论:两组患者的症状均有所缓解,但接受个体营养治疗组患者对低 FODMAP 饮食的依从性优于仅接受如何在线了解低 FODMAP 饮食指导的组患者。
{"title":"[Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].","authors":"Ingunn Erla Ingvarsdottir, Svava Engilbertsdottir, Thorhallur Ingi Halldorsson, Einar Stefan Bjornsson, Ingibjorg Gunnarsdottir","doi":"10.17992/lbl.2024.05.796","DOIUrl":"10.17992/lbl.2024.05.796","url":null,"abstract":"<p><strong>Introduction: </strong>High FODMAP (fermentable oligo-, di, monosaccharides and polyols) foods have been linked with worsening symptoms of IBS patients. The aim was to compare gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet, with or without individual nutrition therapy.</p><p><strong>Materials and methods: </strong>A total of 54 patients that met Rome IV criteria for IBS were randomized into two groups, guided group (individual nutrition therapy, n=28) and self-management group (learned about low FODMAP diet online, n=26). Both groups followed low FODMAP diet for 4 weeks. Four-day food records were used to assess dietary intake. Symptoms were assessed by the IBS-severity scoring system (ISB-SSS).</p><p><strong>Results: </strong>The number of subjects who did not complete the study was 13, thereof five in the nutrition therapy and eight in the self-management group, leaving 23 and 18 subjects available for analysis, respectively. Symptoms declined from baseline to endpoint in both groups, by 183±101 points on average in the group receiving nutrition therapy (p< 0.001) and 132±110 points in the self-management group (p< 0.001), with no difference between groups. At baseline, about 80% of meals in both groups contained food high in FODMAP's. The corresponding proportion was 9% and 36% in week 3 in the nutrition therapy and self-management group, respectively (p< 0.001).</p><p><strong>Conclusion: </strong>Both groups experienced relieve of symptoms, but compliance to the low FODMAP diet was better in the group receiving individual nutrition therapy compared with the group who only received instructions on how to learn about low FODMAP diet online.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 6","pages":"298-306"},"PeriodicalIF":0.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cancer registration in Iceland for 70 years - incidence, mortality and survival]. [冰岛 70 年来癌症登记情况--发病率、死亡率和存活率]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2024-06-01 DOI: 10.17992/lbl.2024.06.797
Alfheidur Haraldsdottir, Helgi Birgisson, Elinborg Jona Olafsdottir, Sigridur Gunnarsdottir, Laufey Tryggvadottir

Introduction: The Icelandic Cancer Registry (ICR) was founded seventy years ago by the Icelandic Cancer Society. In 2007 the ICR became one of the health registers of the Directorate of Health. In this paper we present cancer incidence, mortality, and survival in Iceland over 70 years.

Material and methods: The ICR receives information on cancer diagnoses from histopathological laboratories, the Hospital Discharge Registry and the Cause of Death Registry. Iceland participates in the Nordic cancer database NORDCAN. Because of the small population size, random variation in numbers is very prominent. Therefore, data from ICR are published as five-year averages.

Results: For all malignancies combined, age-standardized incidence (ASI) in men rose steadily until around 15 years ago when a decline started. This is in line with prostate- and lung cancer incidence trends. In women, the ASI was lower than in men, but it is still on the rise despite declining lung cancer incidence. ASI for breast cancer, the most common cancer in women, is increasing. Simultaneously, cancer mortality for both sexes has declined in recent years and cancer survival is improving.

Conclusions: Population-based cancer registration for over 70 years makes it possible to monitor the epidemiology of cancer in Iceland and compare with other countries. The changes in trends in ASI are in line with changes of cancer risk factors and diagnostic policy. The decline in cancer mortality and improvement in survival reflects advances in cancer treatment as well as effects of early detection and prevention.

导言:冰岛癌症登记处(ICR)由冰岛癌症协会于七十年前成立。2007 年,ICR 成为卫生局的健康登记册之一。本文介绍了 70 年来冰岛的癌症发病率、死亡率和存活率:国际癌症登记处从组织病理学实验室、出院登记处和死因登记处获得癌症诊断信息。冰岛加入了北欧癌症数据库 NORDCAN。由于人口规模小,数字的随机变化非常明显。因此,ICR 的数据以五年平均值发布:在所有恶性肿瘤中,男性的年龄标准化发病率(ASI)一直在稳步上升,直到大约 15 年前才开始下降。这与前列腺癌和肺癌的发病趋势一致。女性的年龄标准化发病率低于男性,但尽管肺癌发病率下降,女性的年龄标准化发病率仍呈上升趋势。女性最常见的癌症--乳腺癌的 ASI 正在上升。同时,近年来男女癌症死亡率均有所下降,癌症生存率也在提高:结论:70 多年来基于人口的癌症登记使我们有可能对冰岛的癌症流行病学进行监测,并与其他国家进行比较。ASI趋势的变化与癌症风险因素和诊断政策的变化是一致的。癌症死亡率的下降和生存率的提高反映了癌症治疗的进步以及早期检测和预防的效果。
{"title":"[Cancer registration in Iceland for 70 years - incidence, mortality and survival].","authors":"Alfheidur Haraldsdottir, Helgi Birgisson, Elinborg Jona Olafsdottir, Sigridur Gunnarsdottir, Laufey Tryggvadottir","doi":"10.17992/lbl.2024.06.797","DOIUrl":"10.17992/lbl.2024.06.797","url":null,"abstract":"<p><strong>Introduction: </strong>The Icelandic Cancer Registry (ICR) was founded seventy years ago by the Icelandic Cancer Society. In 2007 the ICR became one of the health registers of the Directorate of Health. In this paper we present cancer incidence, mortality, and survival in Iceland over 70 years.</p><p><strong>Material and methods: </strong>The ICR receives information on cancer diagnoses from histopathological laboratories, the Hospital Discharge Registry and the Cause of Death Registry. Iceland participates in the Nordic cancer database NORDCAN. Because of the small population size, random variation in numbers is very prominent. Therefore, data from ICR are published as five-year averages.</p><p><strong>Results: </strong>For all malignancies combined, age-standardized incidence (ASI) in men rose steadily until around 15 years ago when a decline started. This is in line with prostate- and lung cancer incidence trends. In women, the ASI was lower than in men, but it is still on the rise despite declining lung cancer incidence. ASI for breast cancer, the most common cancer in women, is increasing. Simultaneously, cancer mortality for both sexes has declined in recent years and cancer survival is improving.</p><p><strong>Conclusions: </strong>Population-based cancer registration for over 70 years makes it possible to monitor the epidemiology of cancer in Iceland and compare with other countries. The changes in trends in ASI are in line with changes of cancer risk factors and diagnostic policy. The decline in cancer mortality and improvement in survival reflects advances in cancer treatment as well as effects of early detection and prevention.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 6","pages":"307-314"},"PeriodicalIF":0.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1